Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,477 | -6,864 | -3,266 | -11,728 | -7,675 |
| Depreciation Amortization | 486 | 324 | 162 | 5 | 1 |
| Other Working Capital | 122 | -8 | -323 | 845 | -843 |
| Other Operating Activity | 349 | 266 | 225 | -1,017 | -193 |
| Operating Cash Flow | $-9,520 | $-6,282 | $-3,202 | $-11,895 | $-8,709 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 21 | -30 | -54 | -107 | -14 |
| Net Acquisitions | N/A | N/A | N/A | -2,193 | 57 |
| Investing Cash Flow | $21 | $-30 | $-54 | $-2,300 | $42 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 392 | 392 | 392 | N/A | N/A |
| Debt Repayment | -392 | -259 | -128 | N/A | N/A |
| Common Stock Repurchased | -3,726 | N/A | N/A | -3,206 | N/A |
| Financing Cash Flow | $-3,726 | $133 | $264 | $-3,206 | $N/A |
| Exchange Rate Effect | -7 | -3 | -3 | 10 | -130 |
| Beginning Cash Position | 33,088 | 33,088 | 33,088 | 52,902 | 52,902 |
| End Cash Position | 19,585 | 26,648 | 29,914 | 33,088 | 42,380 |
| Net Cash Flow | $-13,503 | $-6,440 | $-3,174 | $-19,814 | $-10,522 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,520 | -6,282 | -3,202 | -11,895 | -8,709 |
| Capital Expenditure | -34 | -57 | -54 | -107 | -14 |
| Free Cash Flow | -9,554 | -6,339 | -3,256 | -12,002 | -8,724 |